search
Back to results

The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI) (SCI)

Primary Purpose

Spinal Cord Injuries, Hypotension, Orthostatic Hypotension

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Biostim-5 transcutaneous spinal stimulator
Tilt-table orthostatic stress testing
Sponsored by
Kessler Foundation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Cord Injuries focused on measuring Transcutaneous Spinal Cord Stimulation, Spinal Stimulation, Orthostatic Hypotension, Blood Pressure, Neuromodulation

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Spinal cord injury for greater than or equal to 6 months Injury level ≥ T6 (thoracic level) American Spinal Injury Association (ASIA) Impairment Scale (AIS) A-D Exhibits at least one of the following hypotensive symptoms: Baseline hypotension - resting supine or seated systolic blood pressure(SBP) < 90mmHg; SBP drop ≥ 20 mmHg within 5 minutes of assuming seated position; Symptoms of orthostasis with a drop of SBP (<90mmHg) from supine to sitting Exclusion Criteria: Current illness (infection, a pressure injury that might interfere with the intervention, a recent diagnosis of DVT/PE, etc.) Ventilator-dependent History of implanted brain/spine/nerve stimulators Cardiac pacemaker/defibrillator or intra-cardiac lines Significant coronary artery or cardiac conduction disease, a recent history of myocardial infarction Insufficient mental capacity to understand and independently provide consent Pregnancy Cancer Deemed unsuitable by study physician

Sites / Locations

  • Kessler FoundationRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Participants with a chronic SCI (≥ 6 months after injury)

Arm Description

Participants will complete three days of baseline assessments (including a baseline orthostatic test and a day of neurophysiological mapping), five days of stimulation mapping to locate the optimal spinal sites for a blood pressure response, a day of testing with stimulation applied during an orthostatic provocation and a two-week (total of six days) training period with repeated exposure to stimulation, followed by two days of additional orthostatic tests (with and without stimulation)

Outcomes

Primary Outcome Measures

Optimal stimulation sites
Identify scTS spinal segments that restore systolic BP within the normotensive range (110-120 mmHg).
Optimal stimulation frequency
Identify scTS frequency that restores systolic BP within the normotensive range (110-120 mmHg).
Systolic blood pressure - efficacy of stimulation
Evaluate changes in blood pressure during an orthostatic test (comparing measurements obtained during stimulation to those obtained without). The ability of scTS to normalize SBP (to the range of 110-120) and to stabilize it over the course of a 30-min tilt test will be assessed.
Systolic blood pressure - effect of training
Explore the blood pressure response to orthostatic stress with and without stimulation, following six days of repetitive 30-min customized scTS sessions
Orthostatic symptoms questionnaire
A questionnaire ranking the severity of orthostatic symptoms (dizziness, nausea), with a scale of 1-10 (10 being the most severe).

Secondary Outcome Measures

EMG of leg muscles - muscle activation (analysis of mean and peak amplitudes)
Analysis of leg-muscle EMG to identify configurations that modulate BP without eliciting motor activity, to ensure that BP response was not due to lower limb muscle contraction.
Spinal Cord Injury-Quality of Life (SCI-QOL) questionnaires
Accessible through computer adaptive testing and addresses the following domains: emotional health, physical-medical health, social participation, and physical function
Global response assessment (GRA)
GRA will be used to evaluate patients' perceptions of treatment effectiveness
Additional hemodynamic measure - diastolic blood pressure
Hemodynamic measures will be collected throughout the trial
Additional hemodynamic measure - heart rate
Hemodynamic measures will be collected throughout the trial

Full Information

First Posted
January 25, 2023
Last Updated
May 8, 2023
Sponsor
Kessler Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT05725499
Brief Title
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
Acronym
SCI
Official Title
Neuromodulation of Blood Pressure Using Transcutaneous Spinal Stimulation in Chronic Spinal Cord Injury
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 1, 2023 (Actual)
Primary Completion Date
March 2024 (Anticipated)
Study Completion Date
March 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kessler Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
This project will investigate the effect of spinal cord transcutaneous stimulation on blood pressure in individuals with a chronic spinal cord injury who experience blood pressure instability, specifically, orthostatic hypotension (a drop in blood pressure when moving from lying flat on your back to an upright position). The main questions it aims to answer are: What are the various spinal sites and stimulation parameters that normalize and stabilize blood pressure during an orthostatic provocation (70 degrees tilt)? Does training, i.e., exposure to repeated stimulation sessions, have an effect on blood pressure stability? Participants will undergo orthostatic tests (lying on a table that starts out flat, then tilts upward up to 70 degrees), with and without stimulation, and changes in their blood pressure will be evaluated.
Detailed Description
Cardiovascular (CV) control in persons with a high level (thoracic level T6 or above) spinal cord injury (SCI) is often impaired, resulting in short and long-term health complications and a decline in quality of life. Orthostatic hypotension (OH), a significant decrease in blood pressure (BP) when moving from lying flat (supine) to an upright position, appears early after injury and is frequently accompanied by dizziness, weakness, fatigue, and even syncope. In the long term, while symptoms are typically diminished, it still clinically occurs in 50% of individuals with a cervical injury. The physical, social, and emotional consequences of OH pose a major issue. Moreover, BP instability is associated with a decline in CV health and somewhat accounts for the 3 to 4-fold increased risk for stroke and heart disease in this clinical population. In recent years, epidural spinal cord stimulation has been explored with promising results as a potential treatment for CV dysfunction. Spinal cord transcutaneous stimulation (scTS) represents an alternate approach, with the potential to benefit more people with fewer risks. Only one study thus far successfully applied scTS to restore CV function and resolve orthostatic symptoms following SCI, with stimulation applied at one thoracic location. The objective of this study is to investigate the effect of scTS on BP in individuals with chronic SCI who experience OH. Stimulation sites and parameters that consistently increase and stabilize systolic BP within the range of 110-120 mmHg, during an orthostatic provocation (a 70° tilt-test), will be sought. The investigators will also evaluate whether there is any change in the BP response following repeated stimulation sessions. This project will provide the foundational evidence to use scTS to improve autonomic function in various SCI populations and help overcome barriers to engagement in activity and participation imposed by autonomic dysfunction.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries, Hypotension, Orthostatic Hypotension, Spinal Cord Diseases, Cardiovascular Diseases, Trauma, Nervous System, Central Nervous System Diseases, Nervous System Diseases, Blood Pressure
Keywords
Transcutaneous Spinal Cord Stimulation, Spinal Stimulation, Orthostatic Hypotension, Blood Pressure, Neuromodulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
5 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Participants with a chronic SCI (≥ 6 months after injury)
Arm Type
Experimental
Arm Description
Participants will complete three days of baseline assessments (including a baseline orthostatic test and a day of neurophysiological mapping), five days of stimulation mapping to locate the optimal spinal sites for a blood pressure response, a day of testing with stimulation applied during an orthostatic provocation and a two-week (total of six days) training period with repeated exposure to stimulation, followed by two days of additional orthostatic tests (with and without stimulation)
Intervention Type
Device
Intervention Name(s)
Biostim-5 transcutaneous spinal stimulator
Intervention Description
Transcutaneous stimulation of the spinal cord. Mapping will be performed to determine sites for optimal modulation of blood pressure. During each mapping day, with participants in a supine or seated position, electrodes will be placed on the midline of one of the following spinous processes: C5/6, T7/8, T11/12, L1/2 and S1/2. Stimulation intensity will start at 5 mA and gradually increased in 5 mA increments up to 100 mA. The frequency will be 2 or 30 Hz. Profiles will be established to guide selection of optimal site locations for blood pressure modulation. The profile chosen will be used during training and testing. During testing, stimulation will be applied using the selected profile in order to normalize SBP to the range of 110-120 mmHg and stabilize it within this range during a 30-min tilt test. On each session during the 2-week training-period, stimulation will be applied for 30 minutes using the selected profile, while the participant remains in a seated position.
Intervention Type
Diagnostic Test
Intervention Name(s)
Tilt-table orthostatic stress testing
Intervention Description
While lying supine, participants will be strapped to a Hi-Low tilt-table bed. The bed will gradually be tilted to a 70 degrees tilt, during which time continuous hemodynamic measures will be recorded. This position will be maintained for 30 minutes. During some of the sessions, the tilt test will be accompanied by spinal stimulation.
Primary Outcome Measure Information:
Title
Optimal stimulation sites
Description
Identify scTS spinal segments that restore systolic BP within the normotensive range (110-120 mmHg).
Time Frame
Through Mapping and testing sessions, average of 3 weeks
Title
Optimal stimulation frequency
Description
Identify scTS frequency that restores systolic BP within the normotensive range (110-120 mmHg).
Time Frame
Through Mapping and testing sessions, average of 3 weeks
Title
Systolic blood pressure - efficacy of stimulation
Description
Evaluate changes in blood pressure during an orthostatic test (comparing measurements obtained during stimulation to those obtained without). The ability of scTS to normalize SBP (to the range of 110-120) and to stabilize it over the course of a 30-min tilt test will be assessed.
Time Frame
Throughout the experiment, average of 6 weeks
Title
Systolic blood pressure - effect of training
Description
Explore the blood pressure response to orthostatic stress with and without stimulation, following six days of repetitive 30-min customized scTS sessions
Time Frame
Post training, average of 2 weeks
Title
Orthostatic symptoms questionnaire
Description
A questionnaire ranking the severity of orthostatic symptoms (dizziness, nausea), with a scale of 1-10 (10 being the most severe).
Time Frame
Throughout the experiment, average of 6 weeks
Secondary Outcome Measure Information:
Title
EMG of leg muscles - muscle activation (analysis of mean and peak amplitudes)
Description
Analysis of leg-muscle EMG to identify configurations that modulate BP without eliciting motor activity, to ensure that BP response was not due to lower limb muscle contraction.
Time Frame
Through Mapping and testing sessions, average of 3 weeks
Title
Spinal Cord Injury-Quality of Life (SCI-QOL) questionnaires
Description
Accessible through computer adaptive testing and addresses the following domains: emotional health, physical-medical health, social participation, and physical function
Time Frame
Before the first session and after the last session, average of 6 weeks
Title
Global response assessment (GRA)
Description
GRA will be used to evaluate patients' perceptions of treatment effectiveness
Time Frame
post training, average of 6 weeks
Title
Additional hemodynamic measure - diastolic blood pressure
Description
Hemodynamic measures will be collected throughout the trial
Time Frame
throughout the trial, average of 6 weeks
Title
Additional hemodynamic measure - heart rate
Description
Hemodynamic measures will be collected throughout the trial
Time Frame
throughout the trial, average of 6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Spinal cord injury for greater than or equal to 6 months Injury level ≥ T6 (thoracic level) American Spinal Injury Association (ASIA) Impairment Scale (AIS) A-D Exhibits at least one of the following hypotensive symptoms: Baseline hypotension - resting supine or seated systolic blood pressure(SBP) < 90mmHg; SBP drop ≥ 20 mmHg within 5 minutes of assuming seated position; Symptoms of orthostasis with a drop of SBP (<90mmHg) from supine to sitting Exclusion Criteria: Current illness (infection, a pressure injury that might interfere with the intervention, a recent diagnosis of DVT/PE, etc.) Ventilator-dependent History of implanted brain/spine/nerve stimulators Cardiac pacemaker/defibrillator or intra-cardiac lines Significant coronary artery or cardiac conduction disease, a recent history of myocardial infarction Insufficient mental capacity to understand and independently provide consent Pregnancy Cancer Deemed unsuitable by study physician
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
LeighAnn Martinez, BA
Phone
(973)324-3557
Email
lmartinez@kesslerfoundation.org
First Name & Middle Initial & Last Name or Official Title & Degree
Einat Engel-Haber, MD
Email
ehaber@kesslerfoundation.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gail F Forrest, Phd
Organizational Affiliation
Kessler Foundation
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kessler Foundation
City
West Orange
State/Province
New Jersey
ZIP/Postal Code
07052
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
LeighAnn Martinez, BA
Phone
973-324-3557
Email
lmartinez@kesslerfoundation.org
First Name & Middle Initial & Last Name & Degree
Einat Engel-Haber, MD
Email
ehaber@kesslerfoundation.org
First Name & Middle Initial & Last Name & Degree
Gail F Forrest, PhD
First Name & Middle Initial & Last Name & Degree
Steven Kirshblum, MD
First Name & Middle Initial & Last Name & Degree
Einat Engel-Haber, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)

We'll reach out to this number within 24 hrs